Literature DB >> 6385729

Prevention of diabetes mellitus in the BB/W rat with Cyclosporin-A.

A A Like, V Dirodi, S Thomas, D L Guberski, A A Rossini.   

Abstract

Autoimmune diabetes mellitus occurs spontaneously in 40-60% of a colony of BioBreeding/Worcester rats. Pretreatment of susceptible animals for 10-day intervals prior to 70 days of age with Cyclosporin-A (CSA) significantly reduced the frequency and delayed the onset of diabetes. The relatively narrow time frame of successful treatment suggests that effector cells responsible for beta cell destruction in this model of Type I diabetes may be activated during this period of time prior to the onset of overt hyperglycemia. CSA administration did not protect against the occurrence of lymphocytic thyroiditis or autoantibodies directed against smooth muscle or thyroid colloid, suggesting that these BB immunologic phenomena may be controlled by a distinct series of immunologic events.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6385729      PMCID: PMC1900571     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  30 in total

1.  Biological effects of cyclosporin A: a new antilymphocytic agent.

Authors:  J F Borel; C Feurer; H U Gubler; H Stähelin
Journal:  Agents Actions       Date:  1976-07

2.  Cyclosporin A: an immunosuppressive agent preferentially active against proliferating T cells.

Authors:  D J White; A M Plumb; G Pawelec; G Brons
Journal:  Transplantation       Date:  1979-01       Impact factor: 4.939

3.  Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers.

Authors:  R Y Calne; K Rolles; D J White; S Thiru; D B Evans; P McMaster; D C Dunn; G N Craddock; R G Henderson; S Aziz; P Lewis
Journal:  Lancet       Date:  1979-11-17       Impact factor: 79.321

4.  Successful islet transplantation in spontaneous diabetes.

Authors:  A Naji; W K Silvers; S A Plotkin; D Dafoe; C F Barker
Journal:  Surgery       Date:  1979-08       Impact factor: 3.982

5.  Spontaneous diabetes in the gnotobiotic BB/W rat.

Authors:  A A Rossini; R M Williams; J P Mordes; M C Appel; A A Like
Journal:  Diabetes       Date:  1979-11       Impact factor: 9.461

6.  The spontaneously diabetic Wistar rat. Metabolic and morphologic studies.

Authors:  A F Nakhooda; A A Like; C I Chappel; F T Murray; E B Marliss
Journal:  Diabetes       Date:  1977-02       Impact factor: 9.461

7.  Effects of the new anti-lymphocytic peptide cyclosporin A in animals.

Authors:  J F Borel; C Feurer; C Magnée; H Stähelin
Journal:  Immunology       Date:  1977-06       Impact factor: 7.397

8.  Spontaneous diabetes mellitus: reversal and prevention in the BB/W rat with antiserum to rat lymphocytes.

Authors:  A A Like; A A Rossini; D L Guberski; M C Appel; R M Williams
Journal:  Science       Date:  1979-12-21       Impact factor: 47.728

9.  Cyclosporin A to prevent graft-versus-host disease in man after allogeneic bone-marrow transplantation.

Authors:  R L Powles; H M Clink; D Spence; G Morgenstern; J G Watson; P J Selby; M Woods; A Barrett; B Jameson; J Sloane; S D Lawler; H E Kay; D Lawson; T J McElwain; P Alexander
Journal:  Lancet       Date:  1980-02-16       Impact factor: 79.321

10.  In vitro effects of cyclosporin A on lymphocyte subpopulations. 1. Suppressor cell sparing by cyclosporin A.

Authors:  S B Leapman; R S Filo; E J Smith; P G Smith
Journal:  Transplantation       Date:  1980-12       Impact factor: 4.939

View more
  23 in total

1.  Diabetes mellitus in the BB/W rat. Insulitis in pancreatic islet grafts after transplantation in diabetic recipients.

Authors:  E J Weringer; A A Like
Journal:  Am J Pathol       Date:  1986-10       Impact factor: 4.307

2.  A multivalent vaccine for type 1 diabetes skews T cell subsets to Th2 phenotype in NOD mice.

Authors:  Ming S Lin; Hubert M Tse; Meghan M Delmastro; Suzanne Bertera; Caterina T Wong; Robert Lakomy; Jing He; Martha M Sklavos; Gina M Coudriet; Massimo Pietropaolo; Massimo M Trucco; Jon D Piganelli
Journal:  Immunol Res       Date:  2011-08       Impact factor: 2.829

3.  Effects of cyclosporin A on the endocrine pancreas of the rat. Morphological and immunohistochemical studies.

Authors:  R Jablenska; V Ogneva; P Petkov
Journal:  Acta Diabetol Lat       Date:  1989 Jan-Mar

4.  Lack of effect of intermittently administered sodium fusidate in patients with newly diagnosed type 1 diabetes mellitus: the FUSIDM trial.

Authors:  I Conget; E Aguilera; S Pellitero; S Näf; K Bendtzen; R Casamitjana; R Gomis; F Nicoletti
Journal:  Diabetologia       Date:  2005-07-02       Impact factor: 10.122

Review 5.  The epidemiology of diabetes in childhood with special reference to the Orient: implications for mechanism of beta cell damage.

Authors:  A L Drash; N Cho; N Tajima; M Rewers; R Laporte
Journal:  Indian J Pediatr       Date:  1989 Nov-Dec       Impact factor: 1.967

6.  Neonatal injections of cyclosporin enhance autoimmune diabetes in non-obese diabetic mice.

Authors:  P Saï; O Senecat; L Martignat; E Gouin
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

Review 7.  Type 1 diabetes mellitus: an imbalance between effector and regulatory T cells?

Authors:  E J Rashba; E P Reich; C A Janeway; R S Sherwin
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

Review 8.  Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.

Authors:  Diana Faulds; Karen L Goa; Paul Benfield
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

9.  Follow-up of cyclosporin A treatment in type 1 (insulin-dependent) diabetes mellitus: lack of long-term effects.

Authors:  S Martin; G Schernthaner; J Nerup; F A Gries; V A Koivisto; J Dupré; E Standl; P Hamet; R McArthur; M H Tan
Journal:  Diabetologia       Date:  1991-06       Impact factor: 10.122

10.  Thymic epithelial defects and predisposition to autoimmune disease in BB rats.

Authors:  J Doukas; J P Mordes; C Swymer; D Niedzwiecki; R Mason; J Rozing; A A Rossini; D L Greiner
Journal:  Am J Pathol       Date:  1994-12       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.